Routine RTA certificate filing for September 2026 quarter

Compliance View source PDF Explain this filing

QLINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.0%Reaction day

₹651.10

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-2.3% vs market

On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-2.0+0.3-2.3

Next day

-7.2+1.1-8.4

-7.8+1.3-9.2

-5.7+2.0-7.7

-8.6+0.3-8.9

-3.6+1.1-4.7

-12.2-3.2-9.0

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q-Line Biotech submitted a routine quarterly certificate from its Registrar and Share Transfer Agent, Purva Sharegistry, under SEBI Regulation 74(5) for the quarter ended September 30, 2026. The certificate confirms processing of share dematerialisation requests received from depository participants. The attached details show NIL share certificates were dematerialised during September 2026. This is a standard compliance filing with no business or shareholding change.

Likely market impact

Routine compliance filing, no impact on shareholders or stock price.